プロテオミクス市場 – 2029年までの世界予測

Report Overview

The global proteomics market is estimated to reach USD 60.5 billion by 2029 from USD 33.6 billion in 2024, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

世界のプロテオミクス市場は、2024年から2029年の予測期間中にCAGR 12.4%で、2024年の336億米ドルから2029年までに605億米ドルに達すると推定されています。

“The spectroscopy segment holds dominant share in the proteomics market.”

Based on the technology, the proteomics market is divided into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment accounted for the largest share of 48.8% owing to factors such as technique is increased use in protein analysis, providing information about protein structure, size, shape, secondary or tertiary conformation, quantification, and interaction with other molecules, such as ligands, solutes, or other proteins.

“The immunoassay reagent dominated the reagent segments.”

Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents accounted for the largest share of 26.5% of the reagent segment however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques and increasing interest in personalized medicine are likely to drive the segmental growth.

“Biopharmaceutical companies segment is likely to grow at significant CAGR during the forecast period”

Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment accounted for the largest share of 39.1% of the proteomics market owing to rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules, identification of biomarkers and personalized medicine.

“Asia Pacific region estimated to show fastest growth rate.”

Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side – 30%
• By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%

List of Companies Profiled in the Report:

• Thermo fisher Scientific Inc (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Waters Corporation (US)
• Bio-Rad Laboratories, Inc. (US)
• Bruker Corporation (US)
• Revvity (US)
• Shimadzu Corporation (Japan)
• Illumina Inc (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• Qiagen (Netherlands)
• Charles River Laboratories (US)
• Protagene (Germany)
• Creative Proteomics (US)
• Horiba (Japan)
• Sengenics Corporation LLC (US)
• Labvantage-Biomax GmbH (Germany)
• Cell Signaling Technology, Inc. (US)
• FIOS Genomics (UK)
• Azenta Life Sciences (US)
• Medgenome (India)
• Biognosys AG (Switzerland)
• Macrogen Inc (South Korea)

Research Coverage:

This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments such as technology, reagent, service, software, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key Drivers (Growing demand for personalized medicines for clinical practices, Increased investments in proteomics research and development, Rising Application in Drug Discovery and Development and Government and Private Funding) restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics techniques) opportunities (Advancements in Bioinformatics, Advancements in Single-Cell Proteomics and Collaborations and Partnerships) and challenges (Lack of data management/handling in proteomics research) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the proteomics market.
• Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like Thermo fisher Scientific Inc (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Revvity (US), Shimadzu Corporation (Japan), Illumina Inc (US), Promega Corporation (US), Eurofins (Luxembourg), Qiagen (Netherlands), Charles River Laboratories (US), Protagene (Germany), Creative Proteomics (US), Horiba (Japan), Sengenics Corporation LLC (US), Labvantage-Biomax GmbH (Germany), Cell Signaling Technology, Inc. (US), FIOS Genomics (UK), Azenta Life Sciences (US), Medgenome (India), Biognosys AG (Switzerland) and Macrogen Inc (South Korea).

Table of Contents

1            INTRODUCTION            56

1.1         STUDY OBJECTIVES      56

1.2         MARKET DEFINITION   56

1.3         STUDY SCOPE  57

1.3.1      SEGMENTS CONSIDERED          57

1.3.2      INCLUSIONS AND EXCLUSIONS 58

1.3.3      YEARS CONSIDERED     59

1.3.4      CURRENCY CONSIDERED          59

1.4         STAKEHOLDERS            59

1.5         SUMMARY OF CHANGES            60

2            RESEARCH METHODOLOGY     61

2.1         RESEARCH DATA           61

2.1.1      SECONDARY DATA       62

2.1.1.1   Key secondary sources       62

2.1.1.2   Objectives of secondary research     62

2.1.2      PRIMARY DATA 63

2.1.2.1   Objectives of primary research         64

2.2         MARKET SIZE ESTIMATION       64

2.2.1      REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 65

2.2.2      MNM REPOSITORY ANALYSIS   66

2.2.3      PRIMARY INTERVIEWS 66

2.2.4      SECONDARY RESEARCH             67

2.2.5      INSIGHTS FROM PRIMARIES      67

2.2.6      TOP-DOWN APPROACH             68

2.2.7      MARKET GROWTH RATE PROJECTIONS             68

2.3         DATA TRIANGULATION             71

2.4         STUDY ASSUMPTIONS  72

2.5         RESEARCH LIMITATIONS           73

2.6         RISK ANALYSIS 73

3            EXECUTIVE SUMMARY 74

4            PREMIUM INSIGHTS      80

4.1         PROTEOMICS MARKET OVERVIEW        80

4.2         NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2023              81

4.3         SPECTROSCOPY INSTRUMENTATION TECHNOLOGY MARKET, BY TYPE, 2024 VS. 2029        82

4.4         PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              83

5            MARKET OVERVIEW     84

5.1         INTRODUCTION            84

5.2         MARKET DYNAMICS     84

5.2.1      DRIVERS            85

5.2.1.1   Growing demand for personalized medicines in clinical practices             85

5.2.1.2   High investments in pharmaceutical R&D     86

5.2.1.3   Rising applications in drug discovery and development 87

5.2.1.4   Increased private and government funding     87

5.2.2      RESTRAINTS     88

5.2.2.1   High costs of proteomics instruments and technologies             88

5.2.2.2   Lack of standardization      89

5.2.3      OPPORTUNITIES           89

5.2.3.1   Advancements in bioinformatics      89

5.2.3.2   Developments in single-cell proteomics research         90

5.2.3.3   Increasing number of collaborations and strategic partnerships  90

5.2.4      CHALLENGES   91

5.2.4.1   Lack of data management and handling         91

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS       92

5.4         TECHNOLOGY ANALYSIS           93

5.4.1      KEY TECHNOLOGIES    93

5.4.1.1   Mass spectrometry             93

5.4.1.1.1 Intact or top-down protein analysis  93

5.4.1.2   Chromatography 93

5.4.1.3   Protein microarrays           93

5.4.2      COMPLEMENTARY TECHNOLOGIES     94

5.4.2.1   Transcriptomics   94

5.4.2.2   Metabolomics      94

5.4.3      ADJACENT TECHNOLOGIES      94

5.4.3.1   Single-cell proteomics        94

5.5         PRICING ANALYSIS        95

5.5.1      INDICATIVE SELLING PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023             95

5.5.2      AVERAGE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS,

BY REGION, 2023            96

5.6         VALUE CHAIN ANALYSIS            97

5.7         SUPPLY CHAIN ANALYSIS          98

5.8         ECOSYSTEM ANALYSIS 100

5.8.1      PROTEOMICS PRODUCT AND SERVICE PROVIDERS      100

5.8.2      END USERS       102

5.8.3      REGULATORY BODIES  102

5.9         PATENT ANALYSIS        103

5.9.1      METHODOLOGY           103

5.9.2      NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE,

2013–2024          103

5.9.3      INNOVATION AND PATENT APPLICATION        104

5.9.4      TOP TEN PLAYERS WITH HIGHEST NUMBER OF APPLICATIONS              104

5.9.5      TOP 10 PATENT OWNERS          105

5.9.6      KEY PATENTS IN PROTEOMICS MARKET            105

5.10       TRADE ANALYSIS          107

5.10.1    IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)         107

5.10.2    EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)         108

5.10.3    IMPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781) 108

5.10.4    EXPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781) 109

5.11       KEY CONFERENCES AND EVENTS, 2024–2025     110

5.12       REGULATORY LANDSCAPE       111

5.12.1    REGULATORY SCENARIO           111

5.12.1.1 North America     111

5.12.1.2 Europe  111

5.12.1.3 Asia Pacific          112

5.12.1.4 Rest of the world  112

5.12.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          113

5.13       INVESTMENT AND FUNDING SCENARIO            117

5.14       PORTER’S FIVE FORCES ANALYSIS         118

5.14.1    THREAT OF NEW ENTRANTS    119

5.14.2    THREAT OF SUBSTITUTES         119

5.14.3    BARGAINING POWER OF BUYERS           119

5.14.4    BARGAINING POWER OF SUPPLIERS     119

5.14.5    INTENSITY OF COMPETITIVE RIVALRY 119

5.15       KEY STAKEHOLDERS AND BUYING CRITERIA    120

5.15.1    INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS       120

5.15.2    KEY BUYING CRITERIA 121

5.16       IMPACT OF AI/GEN AI ON PROTEOMICS MARKET         122

6            PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY              124

6.1         INTRODUCTION            125

6.2         SPECTROSCOPY            125

6.2.1      MASS SPECTROMETRY 130

6.2.1.1   High specificity and technological advancements to propel segment growth              130

6.2.2      NMR SPECTROSCOPY   134

6.2.2.1   Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth    134

6.2.3      CD SPECTROSCOPY      138

6.2.3.1   Non-destructive and non-invasive techniques to examine changes in secondary protein structures 138

6.3         CHROMATOGRAPHY    142

6.3.1      HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY      146

6.3.1.1   High resolution, sensitivity, and reproducibility to spur segment growth  146

6.3.2      ION CHROMATOGRAPHY          150

6.3.2.1   High resolving power, simplicity, and controllability to separate and purify proteins 150

6.3.3      AFFINITY CHROMATOGRAPHY 154

6.3.3.1   High specificity for target proteins and easy identification of novel protein interactions to drive segment           154

6.3.4      SUPERCRITICAL FLUID CHROMATOGRAPHY    158

6.3.4.1   Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth   158

6.4         ELECTROPHORESIS      162

6.4.1      GEL ELECTROPHORESIS            166

6.4.1.1   Increasing demand for proteomics research and personalized medicine to boost segment growth   166

6.4.2      CAPILLARY ELECTROPHORESIS             170

6.4.2.1   Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market        170

6.5         PROTEIN MICROARRAYS            174

6.5.1      BIOCHIPS          179

6.5.1.1   Lab-on-chips       183

6.5.1.1.1 Rising focus on microfabrication and nanotechnology development to aid segment growth   183

6.5.1.2   Protein chips        187

6.5.1.2.1 Competitive advantage over conventional protein analysis tools to propel segment growth   187

6.5.2      MICROARRAY INSTRUMENTS   192

6.5.2.1   Integrated systems             196

6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins 196

6.5.2.2   Microarray scanners          200

6.5.2.2.1 Cost-effective and high-quality analysis to propel segment growth           200

6.5.2.3   Arrayers 204

6.5.2.3.1 Technological advancements to drive adoption of arrayers in large-scale projects              204

6.6         X-RAY CRYSTALLOGRAPHY       208

6.6.1      RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH            208

6.7         SURFACE PLASMON RESONANCE          212

6.7.1      INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH     212

6.8         PROTEIN FRACTIONATION       216

6.8.1      PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES       216

6.9         OTHER INSTRUMENTATION TECHNOLOGIES  220

7            PROTEOMICS MARKET, BY REAGENT   225

7.1         INTRODUCTION            226

7.2         IMMUNOASSAY REAGENTS       226

7.2.1      NEED FOR RELIABLE, SPECIFIC, AND FAST DISEASE DETECTION AT EARLY STAGES TO FAVOR MARKET GROWTH   226

7.3         SPECTROSCOPY REAGENTS      231

7.3.1      INCREASED ADOPTION OF HIGH-THROUGHPUT MASS SPECTROSCOPY-BASED TECHNIQUES TO AID MARKET GROWTH         231

7.4         CHROMATOGRAPHY REAGENTS            236

7.4.1      BETTER ACCURACY AND LOWER DETECTION LIMITS TO FACILITATE SEGMENT GROWTH     236

7.5         PROTEIN MICROARRAY REAGENTS       240

7.5.1      DEVELOPMENT OF NOVEL AND ADVANCED PROTEIN ANALYSIS REAGENTS TO PROPEL MARKET GROWTH        240

7.6         X-RAY CRYSTALLOGRAPHY REAGENTS 244

7.6.1      EMERGENCE OF NEW TARGETS FOR DRUG DISCOVERY AND HIGH R&D INVESTMENTS TO SUPPORT MARKET GROWTH   244

7.7         ELECTROPHORESIS REAGENTS 248

7.7.1      INCREASING DEMAND FOR 2D ELECTROPHORESIS TO AUGMENT MARKET GROWTH        248

7.8         PROTEIN FRACTIONATION REAGENTS 252

7.8.1      RISING NEED FOR PROTEIN FRACTIONATION TECHNIQUES TO AUGMENT MARKET GROWTH  252

7.9         OTHER REAGENTS        256

8            PROTEOMICS MARKET, BY SERVICE      261

8.1         INTRODUCTION            262

8.2         CORE PROTEOMICS SERVICES  262

8.2.1      PROTEIN IDENTIFICATION SERVICES   266

8.2.1.1   Rising need for protein identification and molecular weight analysis to boost market growth     266

8.2.2      QUANTITATIVE PROTEOMICS SERVICES           271

8.2.2.1   Rapid and low-cost alternatives to help understand global protein expression and modifications       271

8.2.3      PROTEIN CHARACTERIZATION SERVICES          275

8.2.3.1   Characterization studies to help study complex protein structure, drug development, and PTMs    275

8.2.4      PROTEIN PURIFICATION SERVICES       280

8.2.4.1   Protein purification to maximize yield and purity of protein of interest    280

8.2.5      PROTEIN SEPARATION SERVICES          284

8.2.5.1   Technological advancements and use in downstream applications to augment segment growth   284

8.2.6      PROTEIN SEQUENCING SERVICES         288

8.2.6.1   Identification and characterization of PTMs to favor protein sequencing and research 288

8.2.7      CUSTOM ASSAY SERVICES         292

8.2.7.1   Custom assays to improve validation or consistency of protein analysis procedures              292

8.3         BIOINFORMATICS SERVICES     296

8.3.1      LESSER ANALYSIS TIME AND FAVORABLE GOVERNMENT INITIATIVES TO SPUR MARKET GROWTH     296

9            PROTEOMICS MARKET, BY SOFTWARE 301

9.1         INTRODUCTION            302

9.1.1      BIOINFORMATICS TOOLS          302

9.1.1.1   Need for data management and advancements in bioinformatics to augment market growth     302

9.1.2      BIOINFORMATICS DATABASES 306

9.1.2.1   Need to store proteomics data and integrate other omics databases to drive market              306

10          PROTEOMICS MARKET, BY APPLICATION          312

10.1       INTRODUCTION            313

10.2       CLINICAL DIAGNOSTICS            313

10.2.1    CANCER             318

10.2.1.1 Rising prevalence of cancer to propel market growth    318

10.2.2    INFECTIOUS DISEASES 322

10.2.2.1 Technological advancements and need for effective disease diagnosis to support market growth     322

10.2.3    DIABETES         326

10.2.3.1 Need for advanced diagnostic technologies and high diabetes prevalence to aid market growth     326

10.2.4    NEUROLOGICAL DISORDERS    330

10.2.4.1 Growing target patient population and increasing research grants to fuel market growth   330

10.2.5    AUTOIMMUNE DISEASES           334

10.2.5.1 Increasing patient population and growing focus on immunology-based research to propel market growth     334

10.2.6    CARDIOVASCULAR DISEASES   338

10.2.6.1 High burden of cardiovascular diseases to spur adoption of reliable diagnostic tools              338

10.2.7    OTHER CLINICAL DIAGNOSTIC APPLICATIONS 342

10.3       DRUG DISCOVERY & DEVELOPMENT    346

10.3.1    TARGET DISCOVERY    350

10.3.1.1 Increased demand for personalized medicine to support segment growth 350

10.3.2    LEAD IDENTIFICATION 354

10.3.2.1 Lead identification to be essential in drug discovery and characterization 354

10.3.3    LEAD OPTIMIZATION   358

10.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth      358

10.3.4    PRECLINICAL STUDIES 362

10.3.4.1 Integration of proteomics in preclinical studies to refine drug safety and efficacy              362

10.4       OTHER APPLICATIONS 366

11          PROTEOMICS MARKET, BY END USER   371

11.1       INTRODUCTION            372

11.2       BIOPHARMACEUTICAL COMPANIES     372

11.2.1    LOW OPERATING COSTS AND RAPID DRUG ANALYSIS TO DRIVE MARKET            372

11.3       ACADEMIC AND RESEARCH INSTITUTES            376

11.3.1    INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO BOOST MARKET GROWTH        376

11.4       HOSPITALS       381

11.4.1    GROWING PREVALENCE OF IMMUNODEFICIENCY DISEASES AND SERUM PROTEIN DISORDERS TO BOOST MARKET GROWTH     381

11.5       CLINICAL LABORATORIES         385

11.5.1    INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO SUPPORT MARKET GROWTH        385

11.6       OTHER END USERS        389

12          PROTEOMICS MARKET, BY REGION       394

12.1       INTRODUCTION            395

12.2       NORTH AMERICA          396

12.2.1    MACROECONOMIC OUTLOOK FOR NORTH AMERICA   405

12.2.2    US         406

12.2.2.1 US to dominate North American proteomics market during study period 406

12.2.3    CANADA            414

12.2.3.1 Favorable government initiatives and high incidence of cancer to support market growth   414

12.3       EUROPE             422

12.3.1    MACROECONOMIC OUTLOOK FOR EUROPE     430

12.3.2    GERMANY         431

12.3.2.1 Well-established pharmaceutical industry and increased government funding to augment market growth     431

12.3.3    UK         439

12.3.3.1 Developed life science industry and increased academia-industry partnerships to augment market growth     439

12.3.4    FRANCE             447

12.3.4.1 High investments in life science R&D and increased demand for personalized therapeutics to aid market growth    447

12.3.5    SWITZERLAND 455

12.3.5.1 Well-established pharmaceutical and biotechnology industry and increased investments in life science R&D to drive market          455

12.3.6    ITALY   463

12.3.6.1 High private and public R&D funding and favorable government initiatives to favor market growth           463

12.3.7    SPAIN   471

12.3.7.1 Well-established network of research centers, universities, and hospitals to aid market growth     471

12.3.8    REST OF EUROPE           479

12.4       ASIA PACIFIC    487

12.4.1    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          496

12.4.2    CHINA  497

12.4.2.1 Rising government R&D investments and increasing focus on healthcare product manufacturing to fuel market growth             497

12.4.3    JAPAN  505

12.4.3.1 Large geriatric population and strong pharmaceutical research base to drive market   505

12.4.4    INDIA   513

12.4.4.1 Increasing focus on proteomics and genomic research to support market growth              513

12.4.5    SOUTH KOREA 521

12.4.5.1 Developed medical tourism and advanced healthcare infrastructure to propel market growth     521

12.4.6    AUSTRALIA       529

12.4.6.1 Favorable government initiatives and high R&D investments to favor market growth   529

12.4.7    REST OF ASIA PACIFIC  537

12.5       LATIN AMERICA             544

12.5.1    MACROECONOMIC OUTLOOK FOR LATIN AMERICA     552

12.5.2    BRAZIL 553

12.5.2.1 Increasing contract research and manufacturing activities to drive market              553

12.5.3    MEXICO             561

12.5.3.1 Strong pharmaceutical industry and increased government support to augment market growth     561

12.5.4    REST OF LATIN AMERICA          569

12.6       MIDDLE EAST  576

12.6.1    MACROECONOMIC OUTLOOK FOR MIDDLE EAST         584

12.6.2    GCC COUNTRIES           585

12.6.2.1 Saudi Arabia        593

12.6.2.1.1            Increasing government healthcare investments and developing pharmaceuticals industry to boost market growth         593

12.6.2.2 UAE      601

12.6.2.2.1            High R&D expenditure and developed health infrastructure to drive market   601

12.6.2.3 Rest of GCC Countries      609

12.6.3    REST OF MIDDLE EAST 617

12.7       AFRICA 625

12.7.1    FAVORABLE GOVERNMENT INITIATIVES AND ADVANCEMENTS IN PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH      625

12.7.2    MACROECONOMIC OUTLOOK FOR AFRICA       633

13          COMPETITIVE LANDSCAPE       634

13.1       INTRODUCTION            634

13.2       KEY PLAYER STRATEGY/RIGHT TO WIN             634

13.2.1    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET 634

13.3       REVENUE ANALYSIS, 2021–2023 637

13.4       MARKET SHARE ANALYSIS, 2023             637

13.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   640

13.5.1    STARS  640

13.5.2    EMERGING LEADERS    640

13.5.3    PERVASIVE PLAYERS     640

13.5.4    PARTICIPANTS 640

13.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      642

13.5.5.1 Company footprint            642

13.5.5.2 Instrumentation technology footprint            643

13.5.5.3 Reagent footprint 644

13.5.5.4 Service footprint  645

13.5.5.5 Software footprint             645

13.5.5.6 Region footprint  646

13.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          647

13.6.1    PROGRESSIVE COMPANIES       647

13.6.2    RESPONSIVE COMPANIES          647

13.6.3    DYNAMIC COMPANIES 647

13.6.4    STARTING BLOCKS       647

13.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             649

13.7       COMPANY VALUATION AND FINANCIAL METRICS        650

13.8       BRAND/PRODUCT COMPARISON          652

13.9       COMPETITIVE SCENARIO          653

13.9.1    PRODUCT LAUNCHES  653

13.9.2    DEALS  654

13.9.3    EXPANSIONS    655

14          COMPANY PROFILES    656

14.1       KEY PLAYERS   656

14.1.1    THERMO FISHER SCIENTIFIC INC.          656

14.1.1.1 Business overview 656

14.1.1.2 Products/Services/Solutions offered 657

14.1.2    RECENT DEVELOPMENTS         673

14.1.2.1 Product launches 673

14.1.2.2 Deals     674

14.1.2.3 MnM view           675

14.1.2.3.1            Key strengths       675

14.1.2.3.2            Strategic choices  675

14.1.2.3.3            Weaknesses and competitive threats 675

14.1.3    AGILENT TECHNOLOGIES, INC.             676

14.1.3.1 Business overview 676

14.1.3.2 Products/Services/Solutions offered 677

14.1.3.3 Recent developments         682

14.1.3.3.1            Product launches 682

14.1.3.3.2            Deals     683

14.1.3.4 MnM view           684

14.1.3.4.1            Key strengths       684

14.1.3.4.2            Strategic choices  684

14.1.3.4.3            Weaknesses and competitive threats 684

14.1.4    MERCK KGAA   685

14.1.4.1 Business overview 685

14.1.4.2 Products/Services/Solutions offered 686

14.1.4.3 MnM view           689

14.1.4.3.1            Key strengths       689

14.1.4.3.2            Strategic choices  689

14.1.4.3.3            Weaknesses and competitive threats 689

14.1.5    DANAHER CORPORATION         690

14.1.5.1 Business overview 690

14.1.5.2 Products/Services/Solutions offered 691

14.1.5.3 Recent developments         705

14.1.5.3.1            Product launches 705

14.1.5.3.2            Deals     706

14.1.5.4 MnM view           707

14.1.5.4.1            Key strengths       707

14.1.5.4.2            Strategic choices  707

14.1.5.4.3            Weaknesses and competitive threats 707

14.1.6    SHIMADZU CORPORATION       708

14.1.6.1 Business overview 708

14.1.6.2 Products/Services/Solutions offered 709

14.1.6.3 Recent developments         714

14.1.6.3.1            Product launches 714

14.1.6.3.2            Expansions          714

14.1.6.4 MnM view           715

14.1.6.4.1            Key strengths       715

14.1.6.4.2            Strategic choices  715

14.1.6.4.3            Weaknesses and competitive threats 715

14.1.7    WATERS CORPORATION            716

14.1.7.1 Business overview 716

14.1.7.2 Products/Services/Solutions offered 717

14.1.7.3 Recent developments         724

14.1.7.3.1            Product launches 724

14.1.7.3.2            Deals     724

14.1.8    BIO-RAD LABORATORIES, INC. 726

14.1.8.1 Business overview 726

14.1.8.2 Products/Services/Solutions offered 727

14.1.8.3 Recent developments         736

14.1.8.3.1            Product launches 736

14.1.9    BRUKER             737

14.1.9.1 Business overview 737

14.1.9.2 Products/Services/Solutions offered 738

14.1.9.3 Recent developments         745

14.1.9.3.1            Product launches 745

14.1.9.3.2            Deals     746

14.1.10  REVVITY            747

14.1.10.1             Business overview 747

14.1.10.2             Products/Services/Solutions offered 748

14.1.10.3             Recent developments         751

14.1.10.3.1          Deals     751

14.1.11  ILLUMINA, INC. 752

14.1.11.1             Business overview 752

14.1.11.2             Products/Services/Solutions offered 753

14.1.11.3             Recent developments         755

14.1.11.3.1          Deals     755

14.1.12  PROMEGA CORPORATION        756

14.1.12.1             Business overview 756

14.1.12.2             Products/Services/Solutions offered 756

14.1.13  EUROFINS SCIENTIFIC  760

14.1.13.1             Business overview 760

14.1.13.2             Products/Services/Solutions offered 761

14.1.13.3             Recent developments         763

14.1.13.3.1          Deals     763

14.1.14  QIAGEN             764

14.1.14.1             Business overview 764

14.1.14.2             Products/Services/Solutions offered 765

14.1.14.3             Recent developments         769

14.1.14.3.1          Product launches 769

14.1.14.3.2          Deals     769

14.1.15  CHARLES RIVER LABORATORIES            770

14.1.15.1             Business overview 770

14.1.15.2             Products/Services/Solutions offered 771

14.1.15.3             Recent developments         773

14.1.15.3.1          Product launches 773

14.1.15.3.2          Deals     774

14.1.16  PROTAGENE     775

14.1.16.1             Business overview 775

14.1.16.2             Products/Services/Solutions offered 775

14.2       OTHER PLAYERS           778

14.2.1    CREATIVE PROTEOMICS, US     778

14.2.2    HORIBA JAPAN LTD.     780

14.2.3    SENGENICS CORPORATION LLC            781

14.2.4    LABVANTAGE-BIOMAX GMBH  782

14.2.5    FIOS GENOMICS            783

14.2.6    AZENTA US, INC.            784

14.2.7    MEDGENOME  785

14.2.8    BIOGNOSYS AG 786

14.2.9    MACROGEN, INC.           787

14.2.10  CELL SIGNALING TECHNOLOGY, INC.  788

15          APPENDIX         789

15.1       DISCUSSION GUIDE      789

15.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             794

15.3       CUSTOMIZATION OPTIONS      796

15.4       RELATED REPORTS       796

15.5       AUTHOR DETAILS         797

LIST OF TABLES

TABLE 1             PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS              58

TABLE 2             IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS              70

TABLE 3             PROTEOMICS MARKET: RISK ANALYSIS 73

TABLE 4             INDICATIVE PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023 (USD) 95

TABLE 5             PROTEOMICS PRODUCT AND SERVICE PROVIDERS: ROLE IN ECOSYSTEM     101

TABLE 6             END USERS: ROLE IN ECOSYSTEM         102

TABLE 7             REGULATORY BODIES: ROLE IN ECOSYSTEM    102

TABLE 8             NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2013–AUGUST 2024        103

TABLE 9             PROTEOMICS MARKET: TOP 10 PATENT OWNERS, 2013–2023              105

TABLE 10           KEY PATENTS IN PROTEOMICS MARKET, 2021–2024       105

TABLE 11           IMPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)              107

TABLE 12           EXPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)              108

TABLE 13           IMPORT VOLUME FOR MASS SPECTROMETERS (HS CODE: 902781),

2022–2023 (USD)             108

TABLE 14           EXPORT VOLUME FOR MASS SPECTROMETERS (HS CODE-902781),

2022–2023 (USD)             109

TABLE 15           PROTEOMICS MARKET: LIST OF KEY CONFERENCES AND EVENTS,

JANUARY 2024–DECEMBER 2025 110

TABLE 16           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         113

TABLE 17           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114

TABLE 18           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         115

TABLE 19           REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         116

TABLE 20           PROTEOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES              118

TABLE 21           INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR

TOP THREE END USERS             120

TABLE 22           PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)        125

TABLE 23           PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)     126

TABLE 24           PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION,

2022–2029 (USD MILLION)          127

TABLE 25           NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)         127

TABLE 26           EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,

2022–2029 (USD MILLION)          128

TABLE 27           ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,

2022–2029 (USD MILLION)          128

TABLE 28           LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,

2022–2029 (USD MILLION)          129

TABLE 29           MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY,

2022–2029 (USD MILLION)          129

TABLE 30          GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 31           MASS SPECTROMETRY MARKET, BY REGION, 2022–2029 (USD MILLION)          131

TABLE 32           NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          132

TABLE 33           EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          132

TABLE 34           ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          133

TABLE 35           LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          133

TABLE 36           MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          134

TABLE 37           GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          134

TABLE 38           NMR SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)          135

TABLE 39           NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          135

TABLE 40           EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          136

TABLE 41           ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          136

TABLE 42          LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          137

TABLE 43           MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          137

TABLE 44           GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          137

TABLE 45           CD SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)          139

TABLE 46           NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          139

TABLE 47           EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     140

TABLE 48           ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          140

TABLE 49           LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          141

TABLE 50           MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          141

TABLE 51           GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          141

TABLE 52           PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          142

TABLE 53           PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION,

2022–2029 (USD MILLION)          143

TABLE 54           NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 143

TABLE 55           EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY,

2022–2029 (USD MILLION)          144

TABLE 56           ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 144

TABLE 57           LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 145

TABLE 58           MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 145

TABLE 59           GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 146

TABLE 60           HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION,

2022–2029 (USD MILLION)          147

TABLE 61           NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            148

TABLE 62           EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         148

TABLE 63           ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 64           LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 65           MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 66           GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 67           ION CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION) 151

TABLE 68           NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          151

TABLE 69           EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          152

TABLE 70           ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          152

TABLE 71           LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          153

TABLE 72           MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          153

TABLE 73           GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          154

TABLE 74           AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)     155

TABLE 75           NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          155

TABLE 76           EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          156

TABLE 77           ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          156

TABLE 78           LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          157

TABLE 79           MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          157

TABLE 80           GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          158

TABLE 81           SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION,

2022–2029 (USD MILLION)          159

TABLE 82           NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            159

TABLE 83           EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         160

TABLE 84           ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         160

TABLE 85           LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            161

TABLE 86           MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         161

TABLE 87           GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            162

TABLE 88           PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          163

TABLE 89           PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION,

2022–2029 (USD MILLION)          163

TABLE 90           NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)   164

TABLE 91           EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY,

2022–2029 (USD MILLION)          164

TABLE 92          ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)            165

TABLE 93           LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)   165

TABLE 94           MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)   166

TABLE 95           GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)   166

TABLE 96           GEL ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)          167

TABLE 97           NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          168

TABLE 98           EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          168

TABLE 99          ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          169

TABLE 100         LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          169

TABLE 101         MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          170

TABLE 102         GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          170

TABLE 103         CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)     171

TABLE 104         NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          172

TABLE 105         EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          172

TABLE 106         ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          173

TABLE 107         LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          173

TABLE 108         MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          174

TABLE 109         GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          174

TABLE 110        PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 111         PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION,

2022–2029 (USD MILLION)          176

TABLE 112         NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY COUNTRY, 2022–2029 (USD MILLION)            176

TABLE 113        EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)            177

TABLE 114         ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)            177

TABLE 115         LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY COUNTRY, 2022–2029 (USD MILLION)            178

TABLE 116         MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)            178

TABLE 117         GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY COUNTRY, 2022–2029 (USD MILLION)            179

TABLE 118         BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              180

TABLE 119         BIOCHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)              180

TABLE 120         NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181

TABLE 121         EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          181

TABLE 122         ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182

TABLE 123         LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182

TABLE 124         MIDDLE EAST: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183

TABLE 125         GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183

TABLE 126         LAB-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)          184

TABLE 127         NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          185

TABLE 128         EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185

TABLE 129         ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     186

TABLE 130         LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          186

TABLE 131         MIDDLE EAST: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     187

TABLE 132         GCC COUNTRIES: LAB-ON-CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          187

TABLE 133         PROTEIN CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)          189

TABLE 134         NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          189

TABLE 135         EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190

TABLE 136         ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     190

TABLE 137         LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          191

TABLE 138         MIDDLE EAST: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     191

TABLE 139         GCC COUNTRIES: PROTEIN CHIPS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          192

TABLE 140         MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 193

TABLE 141         MICROARRAY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 193

TABLE 142         NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          194

TABLE 143        EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          194

TABLE 144         ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          195

TABLE 145         LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          195

TABLE 146         MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          196

TABLE 147         GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          196

TABLE 148         INTEGRATED SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          197

TABLE 149         NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          197

TABLE 150         EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          198

TABLE 151         ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          198

TABLE 152         LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          199

TABLE 153         MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          199

TABLE 154         GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          200

TABLE 155         MICROARRAY SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION) 201

TABLE 156         NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          201

TABLE 157         EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          202

TABLE 158         ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          202

TABLE 159         LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          203

TABLE 160         MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          203

TABLE 161         GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          204

TABLE 162         ARRAYERS MARKET, BY REGION, 2022–2029 (USD MILLION)              205

TABLE 163         NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     205

TABLE 164         EUROPE: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 165         ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206

TABLE 166         LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207

TABLE 167         MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207

TABLE 168         GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     208

TABLE 169         PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION,

2022–2029 (USD MILLION)          209

TABLE 170         NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,

BY COUNTRY, 2022–2029 (USD MILLION)            209

TABLE 171         EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 210

TABLE 172         ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION) 210

TABLE 173         LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,

BY COUNTRY, 2022–2029 (USD MILLION)            211

TABLE 174         MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,

BY COUNTRY, 2022–2029 (USD MILLION)            211

TABLE 175         GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY,

BY COUNTRY, 2022–2029 (USD MILLION)            212

TABLE 176         PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION,

2022–2029 (USD MILLION)          213

TABLE 177         NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)           213

TABLE 178         EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,

BY COUNTRY, 2022–2029 (USD MILLION)            214

TABLE 179         ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,

BY COUNTRY, 2022–2029 (USD MILLION)            214

TABLE 180         LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,

BY COUNTRY, 2022–2029 (USD MILLION)            215

TABLE 181         MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,

BY COUNTRY, 2022–2029 (USD MILLION)            215

TABLE 182         GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE,

BY COUNTRY, 2022–2029 (USD MILLION)            216

TABLE 183         PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION,

2022–2029 (USD MILLION)          217

TABLE 184         NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,

BY COUNTRY, 2022–2029 (USD MILLION)            217

TABLE 185         EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)       218

TABLE 186         ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)       218

TABLE 187         LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,

BY COUNTRY, 2022–2029 (USD MILLION)            219

TABLE 188         MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,

BY COUNTRY, 2022–2029 (USD MILLION)            219

TABLE 189         GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION,

BY COUNTRY, 2022–2029 (USD MILLION)            220

TABLE 190         PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES,

BY REGION, 2022–2029 (USD MILLION)  221

TABLE 191         NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          222

TABLE 192         EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          222

TABLE 193         ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          223

TABLE 194         LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          223

TABLE 195         MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          224

TABLE 196         GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          224

TABLE 197         PROTEOMICS MARKETS, BY REAGENT, 2022–2029 (USD MILLION)          226

TABLE 198         PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION,

2022–2029 (USD MILLION)          228

TABLE 199         NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            228

TABLE 200         EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     229

TABLE 201         ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            229

TABLE 202         LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            230

TABLE 203         MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            230

TABLE 204         GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            231

TABLE 205         PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION,

2022–2029 (USD MILLION)          232

TABLE 206         NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            233

TABLE 207         EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     233

TABLE 208         ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            234

TABLE 209         LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            235

TABLE 210         MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            235

TABLE 211         GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            236

TABLE 212         PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION,

2022–2029 (USD MILLION)          237

TABLE 213         NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            238

TABLE 214         EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            238

TABLE 215         ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            239

TABLE 216         LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            239

TABLE 217         MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            240

TABLE 218         GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            240

TABLE 219         PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION,

2022–2029 (USD MILLION)          241

TABLE 220         PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     242

TABLE 221         EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            242

TABLE 222         ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            243

TABLE 223         LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            243

TABLE 224         MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            244

TABLE 225         GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)       244

TABLE 226         PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2022–2029 (USD MILLION)        245

TABLE 227         NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)              245

TABLE 228         EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            246

TABLE 229         ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)              246

TABLE 230         LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)              247

TABLE 231         MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)              247

TABLE 232         GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)              248

TABLE 233         PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION,

2022–2029 (USD MILLION)          249

TABLE 234         NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            249

TABLE 235         EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            250

TABLE 236         ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            250

TABLE 237         LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            251

TABLE 238         MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            251

TABLE 239         GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            252

TABLE 240         PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2022–2029 (USD MILLION)        253

TABLE 241         NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION) 253

TABLE 242         EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            254

TABLE 243         ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS,

BY COUNTRY, 2022–2029 (USD MILLION)            254

TABLE 244         LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION) 255

TABLE 245         MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION) 255

TABLE 246         GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION) 256

TABLE 247         PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION,

2022–2029 (USD MILLION)          257

TABLE 248         NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     257

TABLE 249         EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,

2022–2029 (USD MILLION)          258

TABLE 250         ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY,

2022–2029 (USD MILLION)          258

TABLE 251         LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     259

TABLE 252         MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)            259

TABLE 253         GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)     260

TABLE 254         PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)              262

TABLE 255         CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 263

TABLE 256         CORE PROTEOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 263

TABLE 257         NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          264

TABLE 258         EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          264

TABLE 259         ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          265

TABLE 260         LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          265

TABLE 261         MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          266

TABLE 262         GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          266

TABLE 263         PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          268

TABLE 264         NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         268

TABLE 265         EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)        269

TABLE 266         ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          269

TABLE 267         LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         270

TABLE 268         MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          270

TABLE 269         GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         271

TABLE 270         QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          272

TABLE 271         NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         273

TABLE 272         EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          273

TABLE 273         ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         274

TABLE 274         LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         274

TABLE 275         MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         275

TABLE 276         GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         275

TABLE 277         PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          277

TABLE 278         NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         277

TABLE 279         EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          278

TABLE 280         ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         278

TABLE 281         LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2022–2029 (USD MILLION)          279

TABLE 282         MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         279

TABLE 283         GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         280

TABLE 284         PROTEIN PURIFICATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          281

TABLE 285         NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         281

TABLE 286         EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          282

TABLE 287         ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          282

TABLE 288         LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          283

TABLE 289         MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)        283

TABLE 290        GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            284

TABLE 291         PROTEIN SEPARATION SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          285

TABLE 292         NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          285

TABLE 293         EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          286

TABLE 294         ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          286

TABLE 295         LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          287

TABLE 296         MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          287

TABLE 297         GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          288

TABLE 298         PROTEIN SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          289

TABLE 299         NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          290

TABLE 300         EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          290

TABLE 301         ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          291

TABLE 302         LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          291

TABLE 303         MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          292

TABLE 304         GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          292

TABLE 305         CUSTOM ASSAY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 293

TABLE 306         NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          294

TABLE 307         EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          294

TABLE 308         ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          295

TABLE 309         LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          295

TABLE 310         MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          296

TABLE 311         GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          296

TABLE 312         BIOINFORMATICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 298

TABLE 313         NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          298

TABLE 314         EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          299

TABLE 315         ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          299

TABLE 316         LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          300

TABLE 317         MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          300

TABLE 318         GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          300

TABLE 319         PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          302

TABLE 320         PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION,

2022–2029 (USD MILLION)          303

TABLE 321         NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,

BY COUNTRY, 2022–2029 (USD MILLION)            304

TABLE 322         EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)           304

TABLE 323         ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)           305

TABLE 324         LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,

BY COUNTRY, 2022–2029 (USD MILLION)            305

TABLE 325         MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)           306

TABLE 326         GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS,

BY COUNTRY, 2022–2029 (USD MILLION)            306

TABLE 327         PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION,

2022–2029 (USD MILLION)          308

TABLE 328         NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,

BY COUNTRY, 2022–2029 (USD MILLION)            308

TABLE 329         EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)   309

TABLE 330         ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,

BY COUNTRY, 2022–2029 (USD MILLION)            309

TABLE 331         LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,

BY COUNTRY, 2022–2029 (USD MILLION)            310

TABLE 332         MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,

BY COUNTRY, 2022–2029 (USD MILLION)            310

TABLE 333         GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES,

BY COUNTRY, 2022–2029 (USD MILLION)            311

TABLE 334         PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          313

TABLE 335         PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          314

TABLE 336         PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,

2022–2029 (USD MILLION)          315

TABLE 337         NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)            315

TABLE 338        EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)            316

TABLE 339         ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             316

TABLE 340         LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             317

TABLE 341         MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             317

TABLE 342         GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY COUNTRY, 2022–2029 (USD MILLION)            318

TABLE 343         CANCER MARKET, BY REGION, 2022–2029 (USD MILLION)              319

TABLE 344         NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 319

TABLE 345         EUROPE: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          320

TABLE 346         ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          320

TABLE 347         LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 321

TABLE 348         MIDDLE EAST: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 321

TABLE 349         GCC COUNTRIES: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 322

TABLE 350         INFECTIOUS DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)          323

TABLE 351         NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          323

TABLE 352         EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          324

TABLE 353         ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          324

TABLE 354         LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          325

TABLE 355         MIDDLE EAST: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          325

TABLE 356         GCC COUNTRIES: INFECTIOUS DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          326

TABLE 357         DIABETES MARKET, BY REGION, 2022–2029 (USD MILLION)              327

TABLE 358         NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     327

TABLE 359         EUROPE: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          328

TABLE 360         ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 328

TABLE 361         LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 329

TABLE 362         MIDDLE EAST: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 329

TABLE 363         GCC COUNTRIES: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 330

TABLE 364         NEUROLOGICAL DISORDERS MARKET, BY REGION, 2022–2029 (USD MILLION) 331

TABLE 365         NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          331

TABLE 366        EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          332

TABLE 367         ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          332

TABLE 368         LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          333

TABLE 369         MIDDLE EAST: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)        333

TABLE 370         GCC COUNTRIES: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          334

TABLE 371         AUTOIMMUNE DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)          335

TABLE 372         NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          335

TABLE 373         EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          336

TABLE 374         ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          336

TABLE 375         LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          337

TABLE 376         MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          337

TABLE 377         GCC COUNTRIES: PROTEOMICS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)            338

TABLE 378         CARDIOVASCULAR DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION) 339

TABLE 379         NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          339

TABLE 380        EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          340

TABLE 381         ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          340

TABLE 382         LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          341

TABLE 383         MIDDLE EAST: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          341

TABLE 384         GCC COUNTRIES: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          342

TABLE 385         OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION,

2022–2029 (USD MILLION)          343

TABLE 386         NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            343

TABLE 387         EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         344

TABLE 388         ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         344

TABLE 389         LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            345

TABLE 390         MIDDLE EAST: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            345

TABLE 391         GCC COUNTRIES: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            346

TABLE 392         PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE,

2022–2029 (USD MILLION)          347

TABLE 393         PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 347

TABLE 394         NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              348

TABLE 395         EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2022–2029 (USD MILLION)            348

TABLE 396         ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2022–2029 (USD MILLION)            349

TABLE 397         LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              349

TABLE 398         MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY COUNTRY, 2022–2029 (USD MILLION)            350

TABLE 399         GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              350

TABLE 400         TARGET DISCOVERY MARKET, BY REGION, 2022–2029 (USD MILLION)          351

TABLE 401         NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          352

TABLE 402         EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     352

TABLE 403         ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          353

TABLE 404         LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          353

TABLE 405         MIDDLE EAST: TARGET DISCOVERY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          354

TABLE 406        GCC COUNTRIES: TARGET DISCOVERY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          354

TABLE 407         LEAD IDENTIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION)          355

TABLE 408         NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          355

TABLE 409         EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          356

TABLE 410         ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          356

TABLE 411         LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          357

TABLE 412        MIDDLE EAST: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          357

TABLE 413         GCC COUNTRIES: LEAD IDENTIFICATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          358

TABLE 414         LEAD OPTIMIZATION MARKET, BY REGION, 2022–2029 (USD MILLION)          359

TABLE 415         NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          359

TABLE 416         EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     360

TABLE 417         ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          360

TABLE 418         LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          361

TABLE 419         MIDDLE EAST: LEAD OPTIMIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          361

TABLE 420         GCC COUNTRIES: LEAD OPTIMIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          362

TABLE 421         PRECLINICAL STUDIES MARKET, BY REGION, 2022–2029 (USD MILLION)          363

TABLE 422         NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          363

TABLE 423         EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          364

TABLE 424         ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          364

TABLE 425         LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          365

TABLE 426         MIDDLE EAST: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          365

TABLE 427         GCC COUNTRIES: PRECLINICAL STUDIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          366

TABLE 428         PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)          367

TABLE 429         NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           367

TABLE 430         EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)          368

TABLE 431         ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           368

TABLE 432         LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           369

TABLE 433         MIDDLE EAST: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           369

TABLE 434         GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           370

TABLE 435         PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          372

TABLE 436         PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)      373

TABLE 437         NORTH AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              374

TABLE 438         EUROPE: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)            374

TABLE 439         ASIA PACIFIC: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)            375

TABLE 440         LATIN AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              375

TABLE 441         MIDDLE EAST: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)            376

TABLE 442         GCC COUNTRIES: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              376

TABLE 443         PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)      377

TABLE 444         NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 378

TABLE 445         EUROPE: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,

BY COUNTRY, 2022–2029 (USD MILLION)            378

TABLE 446         ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          379

TABLE 447         LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          379

TABLE 448         MIDDLE EAST: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          380

TABLE 449         GCC COUNTRIES: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          380

TABLE 450         PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION) 382

TABLE 451         NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          382

TABLE 452         EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          383

TABLE 453         ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          383

TABLE 454         LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          384

TABLE 455         MIDDLE EAST: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          384

TABLE 456         GCC COUNTRIES: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY,

2022–2029 (USD MILLION)          385

TABLE 457         PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION,

2022–2029 (USD MILLION)          386

TABLE 458         NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES,

BY COUNTRY, 2022–2029 (USD MILLION)            387

TABLE 459         EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)          387

TABLE 460         ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)          388

TABLE 461         LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES,

BY COUNTRY, 2022–2029 (USD MILLION)            388

TABLE 462         MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)          389

TABLE 463         GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL LABORATORIES,

BY COUNTRY, 2022–2029 (USD MILLION)            389

TABLE 464         PROTEOMICS MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)          390

TABLE 465         NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             391

TABLE 466         EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY,

2022–2029 (USD MILLION)          391

TABLE 467         ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            392

TABLE 468         LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             392

TABLE 469        MIDDLE EAST: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)            393

TABLE 470         GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             393

TABLE 471         PROTEOMICS MARKET, BY REGION, 2022–2029 (USD MILLION)              395

TABLE 472         NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          398

TABLE 473         NORTH AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 398

TABLE 474         NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          399

TABLE 475         NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)          399

TABLE 476         NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)            400

TABLE 477         NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       400

TABLE 478         NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION) 400

TABLE 479         NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          401

TABLE 480         NORTH AMERICA: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          401

TABLE 481         NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)     402

TABLE 482         NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          402

TABLE 483         NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          403

TABLE 484         NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          403

TABLE 485         NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        404

TABLE 486         NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       404

TABLE 487         NORTH AMERICA: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          405

TABLE 488         NORTH AMERICA: KEY MACROINDICATORS     406

TABLE 489         US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          407

TABLE 490         US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          408

TABLE 491        US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          408

TABLE 492         US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          409

TABLE 493         US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          409

TABLE 494         US: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              409

TABLE 495         US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 410

TABLE 496         US: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          410

TABLE 497         US: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          411

TABLE 498         US: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     411

TABLE 499         US: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          412

TABLE 500         US: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          412

TABLE 501         US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          413

TABLE 502         US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     413

TABLE 503         US: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          414

TABLE 504         CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          415

TABLE 505         CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          415

TABLE 506         CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          416

TABLE 507         CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          416

TABLE 508         CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          416

TABLE 509         CANADA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          417

TABLE 510         CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          417

TABLE 511         CANADA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION) 418

TABLE 512         CANADA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          418

TABLE 513         CANADA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          419

TABLE 514         CANADA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 419

TABLE 515         CANADA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 420

TABLE 516         CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)        420

TABLE 517         CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       421

TABLE 518         CANADA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 421

TABLE 519         EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 423

TABLE 520         EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          423

TABLE 521         EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          424

TABLE 522         EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          424

TABLE 523         EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          425

TABLE 524        EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          425

TABLE 525         EUROPE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          425

TABLE 526         EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          426

TABLE 527         EUROPE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          426

TABLE 528         EUROPE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          427

TABLE 529         EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          427

TABLE 530         EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 428

TABLE 531         EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 428

TABLE 532        EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          429

TABLE 533         EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       429

TABLE 534         EUROPE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 430

TABLE 535         EUROPE: KEY MACROINDICATORS        431

TABLE 536         GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          432

TABLE 537         GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          433

TABLE 538         GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          433

TABLE 539         GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          434

TABLE 540         GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          434

TABLE 541         GERMANY: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          434

TABLE 542         GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          435

TABLE 543         GERMANY: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION) 435

TABLE 544         GERMANY: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 436

TABLE 545         GERMANY: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          436

TABLE 546         GERMANY: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 437

TABLE 547         GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     437

TABLE 548         GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          438

TABLE 549         GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       438

TABLE 550         GERMANY: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 439

TABLE 551         UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          440

TABLE 552         UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          440

TABLE 553        UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          441

TABLE 554         UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          441

TABLE 555         UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          442

TABLE 556         UK: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              442

TABLE 557         UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 442

TABLE 558         UK: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          443

TABLE 559         UK: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          443

TABLE 560         UK: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     444

TABLE 561         UK: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          444

TABLE 562         UK: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          445

TABLE 563         UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          445

TABLE 564         UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     446

TABLE 565         UK: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          446

TABLE 566         FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          448

TABLE 567         FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          448

TABLE 568         FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)        449

TABLE 569         FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          449

TABLE 570        FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          450

TABLE 571         FRANCE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          450

TABLE 572         FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          450

TABLE 573         FRANCE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          451

TABLE 574         FRANCE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          451

TABLE 575         FRANCE: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          452

TABLE 576         FRANCE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 452

TABLE 577         FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 453

TABLE 578         FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          453

TABLE 579         FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       454

TABLE 580         FRANCE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 454

TABLE 581         SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 456

TABLE 582         SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          456

TABLE 583         SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          457

TABLE 584         SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          457

TABLE 585         SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       458

TABLE 586         SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          458

TABLE 587         SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          459

TABLE 588         SWITZERLAND: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)     459

TABLE 589         SWITZERLAND: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 460

TABLE 590         SWITZERLAND: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          460

TABLE 591         SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)     461

TABLE 592         SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          461

TABLE 593         SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        462

TABLE 594         SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       462

TABLE 595         SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)     463

TABLE 596         ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          464

TABLE 597         ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          464

TABLE 598         ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          465

TABLE 599         ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          465

TABLE 600         ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          466

TABLE 601         ITALY: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              466

TABLE 602         ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          466

TABLE 603         ITALY: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          467

TABLE 604         ITALY: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          467

TABLE 605         ITALY: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          468

TABLE 606         ITALY: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          468

TABLE 607         ITALY: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 469

TABLE 608         ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          469

TABLE 609         ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     470

TABLE 610         ITALY: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          470

TABLE 611         SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          472

TABLE 612         SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          472

TABLE 613         SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          473

TABLE 614         SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          473

TABLE 615         SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          474

TABLE 616         SPAIN: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              474

TABLE 617         SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          474

TABLE 618         SPAIN: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          475

TABLE 619         SPAIN: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          475

TABLE 620         SPAIN: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          476

TABLE 621         SPAIN: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          476

TABLE 622         SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 477

TABLE 623         SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          477

TABLE 624         SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     478

TABLE 625         SPAIN: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          478

TABLE 626         REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 480

TABLE 627         REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          480

TABLE 628         REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)          481

TABLE 629         REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)            481

TABLE 630         REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       482

TABLE 631         REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION) 482

TABLE 632         REST OF EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          483

TABLE 633         REST OF EUROPE: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          483

TABLE 634         REST OF EUROPE: PROTEOMICS MARKET, BY SERVICE,

2022–2029 (USD MILLION)          484

TABLE 635         REST OF EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          484

TABLE 636         REST OF EUROPE: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          485

TABLE 637         REST OF EUROPE: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          485

TABLE 638         REST OF EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        486

TABLE 639         REST OF EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       486

TABLE 640         REST OF EUROPE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)     487

TABLE 641         ASIA PACIFIC: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 489

TABLE 642         ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          489

TABLE 643         ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          490

TABLE 644         ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          490

TABLE 645        ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          491

TABLE 646         ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       491

TABLE 647         ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          491

TABLE 648        ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          492

TABLE 649         ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION) 492

TABLE 650         ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 493

TABLE 651         ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          493

TABLE 652         ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)     494

TABLE 653         ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          494

TABLE 654         ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          495

TABLE 655         ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       495

TABLE 656         ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 496

TABLE 657         ASIA PACIFIC: KEY MACROINDICATORS             497

TABLE 658         CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          498

TABLE 659         CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          498

TABLE 660         CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          499

TABLE 661         CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          499

TABLE 662         CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          500

TABLE 663         CHINA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          500

TABLE 664         CHINA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          500

TABLE 665         CHINA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          501

TABLE 666         CHINA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          501

TABLE 667         CHINA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          502

TABLE 668         CHINA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          502

TABLE 669         CHINA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 503

TABLE 670         CHINA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          503

TABLE 671         CHINA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     504

TABLE 672         CHINA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          504

TABLE 673         JAPAN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          506

TABLE 674         JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          506

TABLE 675         JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          507

TABLE 676         JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          507

TABLE 677         JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          508

TABLE 678         JAPAN: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              508

TABLE 679         JAPAN: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          508

TABLE 680         JAPAN: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          509

TABLE 681         JAPAN: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          509

TABLE 682         JAPAN: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          510

TABLE 683         JAPAN: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          510

TABLE 684         JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 511

TABLE 685         JAPAN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          511

TABLE 686         JAPAN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     512

TABLE 687         JAPAN: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          512

TABLE 688         INDIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)        514

TABLE 689         INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          514

TABLE 690         INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          515

TABLE 691         INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2

022–2029 (USD MILLION)            515

TABLE 692         INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          516

TABLE 693         INDIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              516

TABLE 694         INDIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          517

TABLE 695         INDIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          517

TABLE 696         INDIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          518

TABLE 697         INDIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          518

TABLE 698         INDIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          519

TABLE 699         INDIA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 519

TABLE 700         INDIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          520

TABLE 701         INDIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     520

TABLE 702         INDIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          521

TABLE 703         SOUTH KOREA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 522

TABLE 704         SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          523

TABLE 705         SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          523

TABLE 706         SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          524

TABLE 707         SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       524

TABLE 708         SOUTH KOREA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          524

TABLE 709         SOUTH KOREA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          525

TABLE 710         SOUTH KOREA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)     525

TABLE 711         SOUTH KOREA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 526

TABLE 712         SOUTH KOREA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          526

TABLE 713         SOUTH KOREA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)     527

TABLE 714         SOUTH KOREA: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          527

TABLE 715         SOUTH KOREA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        528

TABLE 716         SOUTH KOREA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 528

TABLE 717         SOUTH KOREA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)     529

TABLE 718         AUSTRALIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          530

TABLE 719         AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          530

TABLE 720         AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          531

TABLE 721         AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          531

TABLE 722         AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          532

TABLE 723         AUSTRALIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          532

TABLE 724         AUSTRALIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          532

TABLE 725         AUSTRALIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION) 533

TABLE 726         AUSTRALIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 533

TABLE 727         AUSTRALIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          534

TABLE 728         AUSTRALIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 534

TABLE 729         AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     535

TABLE 730         AUSTRALIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          535

TABLE 731         AUSTRALIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       536

TABLE 732         AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 536

TABLE 733         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 537

TABLE 734         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)    538

TABLE 735         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)          538

TABLE 736         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)            539

TABLE 737         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY TYPE, 2022–2029 (USD MILLION)       539

TABLE 738         REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION) 539

TABLE 739         REST OF ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          540

TABLE 740         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          540

TABLE 741         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE,

2022–2029 (USD MILLION)          541

TABLE 742        REST OF ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          541

TABLE 743         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          542

TABLE 744         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          542

TABLE 745         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY TYPE, 2022–2029 (USD MILLION)       543

TABLE 746         REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       543

TABLE 747         REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          544

TABLE 748         LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     545

TABLE 749         LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 545

TABLE 750         LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          546

TABLE 751         LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          546

TABLE 752         LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          547

TABLE 753         LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       547

TABLE 754         LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          547

TABLE 755         LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          548

TABLE 756         LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)     548

TABLE 757         LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)     549

TABLE 758         LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          549

TABLE 759         LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          550

TABLE 760         LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          550

TABLE 761         LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        551

TABLE 762         LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       551

TABLE 763         LATIN AMERICA: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          552

TABLE 764         LATIN AMERICA: KEY MACROINDICATORS        553

TABLE 765         BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          554

TABLE 766        BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          554

TABLE 767         BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          555

TABLE 768         BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          555

TABLE 769         BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          556

TABLE 770         BRAZIL: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          556

TABLE 771         BRAZIL: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          556

TABLE 772         BRAZIL: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          557

TABLE 773         BRAZIL: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          557

TABLE 774         BRAZIL: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          558

TABLE 775         BRAZIL: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 558

TABLE 776         BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 559

TABLE 777         BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          559

TABLE 778         BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     560

TABLE 779         BRAZIL: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          560

TABLE 780         MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          562

TABLE 781         MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          562

TABLE 782         MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          563

TABLE 783         MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          563

TABLE 784        MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          564

TABLE 785         MEXICO: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          564

TABLE 786         MEXICO: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          564

TABLE 787         MEXICO: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          565

TABLE 788         MEXICO: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          565

TABLE 789         MEXICO: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          566

TABLE 790         MEXICO: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 566

TABLE 791         MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 567

TABLE 792         MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          567

TABLE 793         MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       568

TABLE 794         MEXICO: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION) 568

TABLE 795         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 569

TABLE 796         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)    570

TABLE 797         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY,

BY TYPE, 2022–2029 (USD MILLION)       570

TABLE 798         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS,

BY TYPE, 2022–2029 (USD MILLION)       571

TABLE 799         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY TYPE, 2022–2029 (USD MILLION)       571

TABLE 800         REST OF LATIN AMERICA: BIOCHIPS MARKET, BY TYPE,

2022–2029 (USD MILLION)          571

TABLE 801         REST OF LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          572

TABLE 802         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          572

TABLE 803         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE,

2022–2029 (USD MILLION)          573

TABLE 804         REST OF LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          573

TABLE 805         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          574

TABLE 806         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          574

TABLE 807         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY TYPE, 2022–2029 (USD MILLION)       575

TABLE 808         REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       575

TABLE 809         REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          576

TABLE 810         MIDDLE EAST: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     576

TABLE 811         MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 577

TABLE 812         MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          577

TABLE 813         MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          578

TABLE 814         MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          578

TABLE 815         MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       579

TABLE 816         MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          579

TABLE 817         MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          580

TABLE 818         MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION) 580

TABLE 819         MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 581

TABLE 820         MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          581

TABLE 821         MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)     582

TABLE 822         MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          582

TABLE 823         MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        583

TABLE 824         MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY TYPE, 2022–2029 (USD MILLION)       583

TABLE 825         MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)     584

TABLE 826         MIDDLE EAST: KEY MACROINDICATORS            585

TABLE 827        GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)            586

TABLE 828         GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 586

TABLE 829        GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          587

TABLE 830         GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)          587

TABLE 831         GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          588

TABLE 832         GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       588

TABLE 833         GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          588

TABLE 834         GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          589

TABLE 835         GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          589

TABLE 836         GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)     590

TABLE 837         GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          590

TABLE 838         GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)        591

TABLE 839         GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          591

TABLE 840         GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        592

TABLE 841         GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       592

TABLE 842         GCC COUNTRIES: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          593

TABLE 843         SAUDI ARABIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 594

TABLE 844         SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)        594

TABLE 845         SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          595

TABLE 846         SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          595

TABLE 847         SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)       596

TABLE 848         SAUDI ARABIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          596

TABLE 849         SAUDI ARABIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          597

TABLE 850         SAUDI ARABIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)     597

TABLE 851         SAUDI ARABIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION) 598

TABLE 852         SAUDI ARABIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          598

TABLE 853         SAUDI ARABIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)     599

TABLE 854         SAUDI ARABIA: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          599

TABLE 855         SAUDI ARABIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)        600

TABLE 856         SAUDI ARABIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 600

TABLE 857         SAUDI ARABIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)     601

TABLE 858         UAE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          602

TABLE 859         UAE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          602

TABLE 860         UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          603

TABLE 861        UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          603

TABLE 862         UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          604

TABLE 863         UAE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)              604

TABLE 864         UAE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     604

TABLE 865         UAE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          605

TABLE 866         UAE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          605

TABLE 867         UAE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     606

TABLE 868         UAE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)          606

TABLE 869         UAE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 607

TABLE 870         UAE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          607

TABLE 871         UAE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     608

TABLE 872         UAE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          608

TABLE 873         REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 610

TABLE 874         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)    610

TABLE 875         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY,

BY TYPE, 2022–2029 (USD MILLION)       611

TABLE 876         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS,

BY TYPE, 2022–2029 (USD MILLION)       611

TABLE 877         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY TYPE, 2022–2029 (USD MILLION)     612

TABLE 878         REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE,

2022–2029 (USD MILLION)          612

TABLE 879         REST OF GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          613

TABLE 880         REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          613

TABLE 881        REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE,

2022–2029 (USD MILLION)          614

TABLE 882         REST OF GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    614

TABLE 883         REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          615

TABLE 884         REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          615

TABLE 885         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY TYPE, 2022–2029 (USD MILLION)       616

TABLE 886         REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       616

TABLE 887         REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          617

TABLE 888         REST OF MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION) 618

TABLE 889         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)    618

TABLE 890         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)          619

TABLE 891         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)            619

TABLE 892         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS,

BY TYPE, 2022–2029 (USD MILLION)       620

TABLE 893         REST OF MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)     620

TABLE 894        REST OF MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          621

TABLE 895         REST OF MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT,

2022–2029 (USD MILLION)          621

TABLE 896         REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE,

2022–2029 (USD MILLION)          622

TABLE 897         REST OF MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          622

TABLE 898        REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE,

2022–2029 (USD MILLION)          623

TABLE 899         REST OF MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          623

TABLE 900         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS,

BY TYPE, 2022–2029 (USD MILLION)       624

TABLE 901         REST OF MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)       624

TABLE 902         REST OF MIDDLE EAST: PROTEOMICS MARKET, BY END USER,

2022–2029 (USD MILLION)          625

TABLE 903         AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2022–2029 (USD MILLION)          626

TABLE 904        AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE,

2022–2029 (USD MILLION)          626

TABLE 905         AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE,

2022–2029 (USD MILLION)          627

TABLE 906         AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE,

2022–2029 (USD MILLION)          627

TABLE 907         AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE,

2022–2029 (USD MILLION)          628

TABLE 908         AFRICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)          628

TABLE 909         AFRICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          628

TABLE 910         AFRICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)          629

TABLE 911         AFRICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)          629

TABLE 912         AFRICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)          630

TABLE 913         AFRICA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION) 630

TABLE 914         AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 631

TABLE 915         AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE,

2022–2029 (USD MILLION)          631

TABLE 916         AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)     632

TABLE 917         AFRICA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)          632

TABLE 918         AFRICA: KEY MACROINDICATORS         633

TABLE 919         OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEOMICS MARKET 634

TABLE 920         PROTEOMICS MARKET: DEGREE OF COMPETITION      638

TABLE 921         PROTEOMICS MARKET: INSTRUMENTATION TECHNOLOGY FOOTPRINT      643

TABLE 922         PROTEOMICS MARKET: REAGENT FOOTPRINT 644

TABLE 923         PROTEOMICS MARKET: SERVICE FOOTPRINT  645

TABLE 924         PROTEOMICS MARKET: SOFTWARE FOOTPRINT            645

TABLE 925         PROTEOMICS MARKET: REGION FOOTPRINT   646

TABLE 926         PROTEOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS           649

TABLE 927         PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES           650

TABLE 928         PROTEOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024    653

TABLE 929         PROTEOMICS MARKET: DEALS, JANUARY 2021–AUGUST 2024              654

TABLE 930         PROTEOMICS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024      655

TABLE 931         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              656

TABLE 932         THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   657

TABLE 933         THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES,

JANUARY 2021–AUGUST 2024     673

TABLE 934         THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024    674

TABLE 935         AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 676

TABLE 936         AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   677

TABLE 937         AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–AUGUST 2024     682

TABLE 938         AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024    683

TABLE 939         MERCK KGAA: COMPANY OVERVIEW    685

TABLE 940         MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED              686

TABLE 941         DANAHER CORPORATION: COMPANY OVERVIEW         690

TABLE 942         DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   691

TABLE 943         DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024        705

TABLE 944         DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2024      706

TABLE 945         SHIMADZU CORPORATION: COMPANY OVERVIEW        708

TABLE 946         SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   709

TABLE 947         SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024        714

TABLE 948         SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024    714

TABLE 949         WATERS CORPORATION: COMPANY OVERVIEW             716

TABLE 950         WATERS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED          717

TABLE 951         WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024        724

TABLE 952         WATERS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024              724

TABLE 953         BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW  726

TABLE 954         BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   727

TABLE 955         BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–AUGUST 2024     736

TABLE 956         BRUKER: COMPANY OVERVIEW 737

TABLE 957         BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 738

TABLE 958         BRUKER: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024              745

TABLE 959         BRUKER: DEALS, JANUARY 2021–AUGUST 2024  746

TABLE 960         REVVITY: COMPANY OVERVIEW            747

TABLE 961         REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED              748

TABLE 962         REVVITY: DEALS, JANUARY 2021–AUGUST 2024 751

TABLE 963         ILLUMINA, INC.: COMPANY OVERVIEW 752

TABLE 964         ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED              753

TABLE 965         ILLUMINA, INC.: DEALS, JANUARY 2021–AUGUST 2024   755

TABLE 966         PROMEGA CORPORATION: COMPANY OVERVIEW         756

TABLE 967         PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   756

TABLE 968         EUROFINS SCIENTIFIC: COMPANY OVERVIEW  760

TABLE 969         EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED          761

TABLE 970         EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–AUGUST 2024              763

TABLE 971         QIAGEN: COMPANY OVERVIEW 764

TABLE 972         QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED 765

TABLE 973         QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024              769

TABLE 974         QIAGEN: DEALS, JANUARY 2021–AUGUST 2024  769

TABLE 975         CHARLES RIVER LABORATORIES: COMPANY OVERVIEW              770

TABLE 976         CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED   771

TABLE 977         CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES,

JANUARY 2021–AUGUST 2024     773

TABLE 978         CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–AUGUST 2024    774

TABLE 979         PROTAGENE: COMPANY OVERVIEW     775

TABLE 980         PROTAGENE: PRODUCTS/SERVICES/SOLUTIONS OFFERED              775

TABLE 981         CREATIVE PROTEOMICS, US: COMPANY OVERVIEW      778

TABLE 982         HORIBA JAPAN LTD.: COMPANY OVERVIEW      780

TABLE 983         SENGENICS CORPORATION LLC: COMPANY OVERVIEW              781

TABLE 984         LABVANTAGE-BIOMAX GERMANY GMBH: COMPANY OVERVIEW        782

TABLE 985         FIOS GENOMICS: COMPANY OVERVIEW             783

TABLE 986         AZENTA US, INC.: COMPANY OVERVIEW            784

TABLE 987         MEDGENOME: COMPANY OVERVIEW   785

TABLE 988         BIOGNOSYS AG: COMPANY OVERVIEW 786

TABLE 989         MACROGEN, INC.: COMPANY OVERVIEW           787

TABLE 990         CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW              788

LIST OF FIGURES

FIGURE 1           PROTEOMICS MARKET: SEGMENTS CONSIDERED         57

FIGURE 2           PROTEOMICS MARKET: YEARS CONSIDERED    59

FIGURE 3           PROTEOMICS MARKET: RESEARCH DESIGN      61

FIGURE 4           PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES    63

FIGURE 5           MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS     64

FIGURE 6           MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS              65

FIGURE 7           ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023) 66

FIGURE 8           PROTEOMICS MARKET: MARKET VALIDATION FROM PRIMARY EXPERTS        67

FIGURE 9           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       68

FIGURE 10         PROTEOMICS MARKET: CAGR PROJECTION      69

FIGURE 11         PROTEOMICS MARKET: DATA TRIANGULATION            71

FIGURE 12         PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY,

2024 VS. 2029 (USD MILLION)     74

FIGURE 13         PROTEOMICS MARKET, BY REAGENT, 2024 VS. 2029 (USD MILLION)          75

FIGURE 14         PROTEOMICS MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)          76

FIGURE 15         PROTEOMICS MARKET, BY SOFTWARE, 2024 VS. 2029 (USD MILLION)          77

FIGURE 16         PROTEOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)          77

FIGURE 17         PROTEOMICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          78

FIGURE 18         PROTEOMICS MARKET: REGIONAL GROWTH OPPORTUNITIES              79

FIGURE 19         INCREASED R&D INVESTMENTS AND HIGH DEMAND FOR PERSONALIZED MEDICINES TO DRIVE MARKET             80

FIGURE 20         US AND CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF

NORTH AMERICAN PROTEOMICS MARKET IN 2023        81

FIGURE 21         MASS SPECTROMETRY SEGMENT TO DOMINATE MARKET IN 2029      82

FIGURE 22         CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029      83

FIGURE 23         PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    84

FIGURE 24         PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2023              85

FIGURE 25         PROTEOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   92

FIGURE 26         INDICATIVE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS, BY REGION, 2023 (USD THOUSAND)     96

FIGURE 27         PROTEOMICS PRODUCTS MARKET: VALUE CHAIN ANALYSIS              97

FIGURE 28         PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS         98

FIGURE 29         PROTEOMICS MARKET: ECOSYSTEM ANALYSIS 100

FIGURE 30         NUMBER OF PATENTS GRANTED ANNUALLY, 2013–2023              104

FIGURE 31         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS,

2013–2023          104

FIGURE 32         PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS              118

FIGURE 33         KEY BUYING CRITERIA FOR TOP FOUR END USERS        121

FIGURE 34         PROTEOMICS MARKET: IMPACT OF AI/GEN AI 123

FIGURE 35         NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT  397

FIGURE 36         ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT          488

FIGURE 37         REVENUE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2021–2023)     637

FIGURE 38         MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2023) 638

FIGURE 39         PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 641

FIGURE 40         PROTEOMICS MARKET: COMPANY FOOTPRINT             642

FIGURE 41         PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023             648

FIGURE 42         EV/EBITDA OF KEY VENDORS   650

FIGURE 43         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS          651

FIGURE 44         PROTEOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS          652

FIGURE 45         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT              657

FIGURE 46         AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 677

FIGURE 47         MERCK KGAA: COMPANY SNAPSHOT    686

FIGURE 48         DANAHER CORPORATION: COMPANY SNAPSHOT         691

FIGURE 49         SHIMADZU CORPORATION: COMPANY SNAPSHOT       709

FIGURE 50         WATERS CORPORATION: COMPANY SNAPSHOT            717

FIGURE 51         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 727

FIGURE 52         BRUKER: COMPANY SNAPSHOT             738

FIGURE 53         REVVITY: COMPANY SNAPSHOT            748

FIGURE 54         ILLUMINA, INC.: COMPANY SNAPSHOT 753

FIGURE 55         EUROFINS SCIENTIFIC: COMPANY SNAPSHOT  761

FIGURE 56         QIAGEN: COMPANY SNAPSHOT             765

FIGURE 57         CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT              771

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
• 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
• オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
• 建設重機市場 – 2030年までの世界予測 2025-04-03
• 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02

MarketsandMarkets  出版レポート一覧